Дело T-***/**: *****************, Определение от **.**.2018 г.

Текст

... — Manifest inadmissibility)

In Case T‑666/17,

NeoCell Corporation, represented by M. Edenborough QC,

applicant,

v

European Union Intellectual Property Office (EUIPO), represented by A. Lukošiūtė, acting as Agent,

defendant,

ACTION brought against the decision of the Second Board of Appeal of EUIPO of 18 July 2017 (Case R 147/2017‑2), relating to the international registration designating the European Union in respect of the word mark BIOACTIVE NEOCELL COLLAGEN,

THE GENERAL COURT (Eighth Chamber),

composed of A.M. Collins, President, M. Kancheva (Rapporteur) and G. De Baere, Judges,

Registrar: E. Coulon,

having regard to the application lodged at the Court Registry on 29 September 2017,

having regard to the plea of inadmissibility raised by EUIPO by document lodged at the Court Registry on 15 January 2018,

makes the following

Order

Facts and procedure

1. By application lodged at the Registry of the General Court on 29 September 2017, an action was brought on behalf of the applicant, NeoCell Corporation, by M. Edenborough QC, for the purposes of annulment of the decision of the Second Board of Appeal of EUIPO of 18 July 2017 (Case R 147/2017‑2) dismissing the appeal brought against the decision of the examiner refusing to protect, by means of an EU trade mark, international registration No 1298829 in respect of the word mark BIOACTIVE NEOCELL COLLAGEN. In the application, the applicant appeared to be a company governed by the laws of California (United States) with its registered address at ‘17500 Gillette Avenue, Irvine, California 92614, United States of America’.

2. ...